Abstract
Objective:
To assess preptin concentrations in pregnant women with and without gestational diabetes mellitus (GDM) and in the cord blood of their fetuses.
Study Design:
In all, 31 pregnant women with GDM and 31 gestational age-matched healthy pregnant subjects participated. Maternal serum and cord blood preptin levels were measured with ELISA. The relationships between maternal serum and cord blood preptin levels, anthropometric and metabolic parameters were also assessed.
Result:
Maternal serum and cord blood preptin levels were found higher in patients with GDM compared with control pregnant women. Preptin concentration in maternal serum was positively correlated with maternal age, fasting insulin levels, 1-h blood glucose after glucose load and cord preptin concentrations at birth. However, relationships between maternal and/or cord serum preptin and fetal growth parameters at birth were not detected.
Conclusion:
Our results indicate that preptin concentrations increase in maternal serum of women with GDM. Preptin levels may provide a novel approach to identify women with GDM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Metzger BE, Coustan DR (eds). Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl. 2): B1–B167.
American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2001; 24 (Suppl. 1): S77–S79.
Coustan DR . Making the diagnosis of gestational diabetes mellitus. Clin Obstet Gynecol 2000; 43: 99–105.
Buchanan CM, Phillips AR, Cooper GJ . Preptin derived from proinsulin like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 2001; 360: 431–439.
Cooper G, Willis A, Clark A, Turner R, Sim R, Reid K . Purification and characterization of a peptide from amyloidrich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 84: 8628–8632.
Yang G, Li L, Chen W, Liu H, Boden G, Li K . Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Ann Med 2009; 41 (1): 52–56.
Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Liu YS, Lu Y, Liu W, Xie H, Luo XH, Wu XP et al. Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts. Amino Acids 2010; 38: 763–769.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Aslan, M., Celik, O., Karsavuran, N. et al. Maternal serum and cord blood preptin levels in gestational diabetes mellitus. J Perinatol 31, 350–355 (2011). https://doi.org/10.1038/jp.2010.125
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.125
Keywords
This article is cited by
-
Is gestational diabetes mellitus an independent risk factor for macrosomia: a meta-analysis?
Archives of Gynecology and Obstetrics (2015)
-
The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level
Reproductive Biology and Endocrinology (2012)